abstract
Highlights
- •We aimed to determine the frequency of uterine involvement in patients with BOT.
- •We evaluated the recurrence risk and survival after hysterectomy.
- •Fertility-sparing surgery was associated with more recurrent BOT.
- •Fertility-sparing surgery was associated with more ovarian invasive disease.
- •Hysterectomy affected favorably borderline disease-free survival.
Abstract
Objective
To
determine the frequency of uterine involvement in patients with
borderline ovarian tumors (BOT) and to evaluate the recurrence risk and
survival after hysterectomy.
Materials and methods
In
two French hospitals: A tertiary referral centre (University hospital
centre of Tours, France) and the Alliance community hospital of Tours
(France), we reviewed data of consecutive women undergoing surgery for
presumed stage I BOT between January 1997 and December 2012. Patients
were divided into two groups: patients treated with fertility sparing
surgery (group 1) and those treated with radical surgery (group 2).
Results
A
total of 135 patients were evaluated. 35 had fertility sparing surgery,
81 had radical surgery with hysterectomy and 19 had previous
hysterectomy for other reasons. There were more recurrent borderline
ovarian disease and more ovarian invasive disease developed in group 1
(p = 0.02, p = 0.04, respectively). Hysterectomy affected favorably
borderline disease-free survival, OR = 0.09 95%CI (0.005–0.69),
p = 0.04, but perceived benefits may be related to bilateral
salpingo-oophorectomy and not hysterectomy directly.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.